Baker Avenue Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Baker Avenue Asset Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10	Closed	-$561	–	1580
2023 Q3	$561	Hold	10	–	–	﹤0.01%	1413
2023 Q2	$505	Hold	10	–	–	﹤0.01%	1401
2023 Q1	$546	Hold	10	–	–	﹤0.01%	1393
2022 Q4	$625	Buy	+10	New	+$664	﹤0.01%	1242

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Baker Avenue Asset Management's AXNX Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 10 shares — an estimated $561 sold.

Baker Avenue Asset Management first reported a position in AXNX in Q4 2022 and held it in 4 quarters. The position peaked at $625 in Q4 2022. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Baker Avenue Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 10 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $561.
Baker Avenue Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Baker Avenue Asset Management's Axonics, Inc. Common Stock position peaked at $625 in Q4 2022.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.